Sustained and Improved Efficacy of Tildrakizumab from Week 28 to Week 52 in Treating Moderate-to-Severe Plaque Psoriasis

Boni Elewski, Alan Menter, Jeffrey Crowley, Stephen Tyring, Yang Zhao, Simon Lowry, Stephen Rozzo, Alan Mendelsohn, Jeffrey Parno, Kenneth Gordon

Abstract


Abstract not available.

 

Disclosures: Study sponsored by SUN PHARMA.

 

Copyright SKIN 2018


Keywords


psoriasis; tildrakizumab

Full Text: Poster PDF

DOI: 10.25251/skin.2.supp.22

Abstract - 131 Poster PDF - 51

Refbacks

  • There are currently no refbacks.

ISSN: 2574-1624

x
Message